Sana Biotechnology Inc expected to post a loss of 21 cents a share - Earnings Preview

Sana Biotechnology

04/08/2025 12:01

Sana Biotechnology Inc SANA.OQ SANA.O is expected to  show no change in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Sana Biotechnology Inc is for a loss of 21 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Sana Biotechnology Inc is $9.00, about 56.6% above its last closing price of $3.91

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.23
-0.23
-0.21
Beat
8.5
Dec. 31 2025
-0.23
-0.21
Beat
7.2
Sep. 30 2024
-0.25
-0.25
-0.25
Met
-0.1​
Jun. 30 2024
-0.28
-0.28
-0.21
Beat
26.3
​​Mar. 31 2024
-0.33
-0.32
-0.49
Missed
-54.1
Dec. 31 2023
-0.38
-0.38
-0.41
Missed
-7.9​
Sep. 30 2023
-0.43
-0.45
0.02
Beat
104.5
Jun. 30 2023
-0.42
-0.43
-0.59
Missed
-38.3

This summary was machine generated August 4 at 11:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)